Asher Chanan-Khan
Directeur/Membre du Conseil chez CELLECTAR BIOSCIENCES, INC.
Fortune : - $ au 31/05/2024
Profil
Asher Alban Chanan-Khan is an Independent Director at Cellectar Biosciences, Inc. and a Director at Starton Therapeutics, Inc. He previously served as a Director at Mayo Clinic Jacksonville and Jacksonville Zoological Society, Inc. Additionally, he was a Professor-Medicine & Oncology at Mayo Clinic College of Medicine & Science from 2011 to 2018.
Dr. Chanan-Khan holds a doctorate degree from New York University and Vagelos College of Physicians & Surgeons, and an undergraduate degree from Allama Iqbal Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Asher Chanan-Khan
| Sociétés | Poste | Début |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Directeur/Membre du Conseil | 24/06/2021 |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Directeur/Membre du Conseil | - |
Anciens postes connus de Asher Chanan-Khan
| Sociétés | Poste | Fin |
|---|---|---|
| Mayo Clinic College of Medicine & Science | Corporate Officer/Principal | 01/01/2018 |
Jacksonville Zoological Society, Inc.
 Jacksonville Zoological Society, Inc. Other Consumer ServicesConsumer Services Jacksonville Zoological Society, Inc. operates as a non-profit organization that engages in the management of a zoo. The company is headquartered in Jacksonville, FL. | Directeur/Membre du Conseil | - |
Mayo Clinic Jacksonville
 Mayo Clinic Jacksonville Hospital/Nursing ManagementHealth Services Mayo Clinic Jacksonville provides health care services. It specializes in transplant program, including bone-marrow, heart-lung, kidney, and pancreas. The company was founded in 1986 and is headquartered in Jacksonville, FL. | Directeur/Membre du Conseil | - |
Formation de Asher Chanan-Khan
| New York University | Doctorate Degree |
| Allama Iqbal Medical College | Undergraduate Degree |
| Vagelos College of Physicians & Surgeons | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mayo Clinic Jacksonville
Mayo Clinic Jacksonville Hospital/Nursing ManagementHealth Services Mayo Clinic Jacksonville provides health care services. It specializes in transplant program, including bone-marrow, heart-lung, kidney, and pancreas. The company was founded in 1986 and is headquartered in Jacksonville, FL. | Health Services |
Jacksonville Zoological Society, Inc.
Jacksonville Zoological Society, Inc. Other Consumer ServicesConsumer Services Jacksonville Zoological Society, Inc. operates as a non-profit organization that engages in the management of a zoo. The company is headquartered in Jacksonville, FL. | Consumer Services |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
